Sawabe T et al. |
Sinus arrest during tacrolimus (FK506) and digitalis treatment in a bone marrow transplant recipient. |
1997 |
Transplantation |
pmid:9233725
|
Egawa H et al. |
FK506 conversion therapy in pediatric liver transplantation. |
1994 |
Transplantation |
pmid:7513911
|
Ciancio G et al. |
Randomized trial of three induction antibodies in kidney transplantation: long-term results. |
2014 |
Transplantation |
pmid:24477186
|
Eason JD et al. |
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. |
2003 |
Transplantation |
pmid:12717237
|
Hougardy JM et al. |
The once-daily formulation of tacrolimus: a step forward in kidney transplantation? |
2012 |
Transplantation |
pmid:22234346
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Drachenberg CB et al. |
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. |
1999 |
Transplantation |
pmid:10459544
|
Firdaous I et al. |
Pediatric intravenous FK506--how much are we really infusing? |
1994 |
Transplantation |
pmid:7517079
|
Shihab FS et al. |
Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. |
1997 |
Transplantation |
pmid:9422427
|
Vu MD et al. |
Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. |
1997 |
Transplantation |
pmid:9422432
|
Deuse T et al. |
The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent. |
2004 |
Transplantation |
pmid:15084926
|
Ferraris JR et al. |
Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses. |
2004 |
Transplantation |
pmid:15084930
|
Shapiro R et al. |
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10628763
|
Andrés A et al. |
A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration. |
2009 |
Transplantation |
pmid:19898206
|
Selzner N et al. |
Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. |
2001 |
Transplantation |
pmid:11579301
|
Murase N et al. |
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. |
1990 |
Transplantation |
pmid:1700504
|
Newell KA et al. |
Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. |
1997 |
Transplantation |
pmid:9381541
|
Burke MD et al. |
Inhibition of the metabolism of cyclosporine by human liver microsomes by FK506. |
1990 |
Transplantation |
pmid:1700507
|
Grudé P et al. |
MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation. |
2002 |
Transplantation |
pmid:12085008
|
Xu X et al. |
FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. |
2002 |
Transplantation |
pmid:12085010
|
Erden E et al. |
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. |
1994 |
Transplantation |
pmid:7519801
|
Morikawa K et al. |
The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. |
1992 |
Transplantation |
pmid:1281561
|
Moutabarrik A et al. |
FK506-induced kidney tubular cell injury. |
1992 |
Transplantation |
pmid:1281562
|
Saliba F et al. |
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study. |
2016 |
Transplantation |
pmid:27454919
|
Tokita D et al. |
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. |
2008 |
Transplantation |
pmid:18301333
|
Pérgola PE et al. |
Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. |
2001 |
Transplantation |
pmid:11349738
|
Moffatt SD et al. |
STAT 6 up-regulation by FK506 in the presence of interleukin-4. |
2000 |
Transplantation |
pmid:10798785
|
Homma M et al. |
Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. |
2002 |
Transplantation |
pmid:11821750
|
Meier M et al. |
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. |
2006 |
Transplantation |
pmid:16612281
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
Brunet M et al. |
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16495801
|
Chen H et al. |
Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus. |
2000 |
Transplantation |
pmid:10836361
|
Hougardy JM et al. |
Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure. |
2011 |
Transplantation |
pmid:21192316
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Dhar DK et al. |
The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. |
1992 |
Transplantation |
pmid:1384188
|
Ericzon BG et al. |
FK506-induced impairment of glucose metabolism in the primate--studies in pancreatic transplant recipients and in nontransplanted animals. |
1992 |
Transplantation |
pmid:1384189
|
Bayés B et al. |
Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. |
2004 |
Transplantation |
pmid:15257035
|
Wang X et al. |
Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. |
2005 |
Transplantation |
pmid:15940043
|
Jordan ML et al. |
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. |
1994 |
Transplantation |
pmid:7512293
|
Kashu Y et al. |
The effect of combination splenectomy and low-dose FK506 therapy on graft survival after liver allograft transplantation in rats. |
1996 |
Transplantation |
pmid:8633382
|
Pascher A et al. |
Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation. |
2003 |
Transplantation |
pmid:12923454
|
Scheel AK et al. |
Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750573
|
Jain AB et al. |
FK 506 dosage in human organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689890
|
Morris-Stiff G et al. |
Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases. |
1998 |
Transplant. Proc. |
pmid:9636525
|
Burke GW et al. |
Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9532153
|
Kuroki H et al. |
Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. |
1993 |
Transplant. Proc. |
pmid:7679833
|
Machida M et al. |
Effect of temperature and hematocrit on plasma concentration of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721266
|
Ko S et al. |
Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623229
|
Tsang WK et al. |
Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients. |
2000 |
Transplant. Proc. |
pmid:11119921
|
Chan KL et al. |
Porcine small bowel transplantation with FK506 as a single immunosuppressant. |
2001 |
Transplant. Proc. |
pmid:11406260
|
Stratta RJ et al. |
FK 506 induction and rescue therapy in pancreas transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623492
|
O'Neill EA et al. |
The FK 506-sensitive nature of the interleukin-2 promoter is derived from a specific array of multiple regulatory elements. |
1991 |
Transplant. Proc. |
pmid:1721298
|
Merli M et al. |
Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. |
2010 |
Transplant. Proc. |
pmid:20534292
|
Uchida H et al. |
Chronopharmacology of tacrolimus in rats: toxicity and efficacy in a mouse-to-rat intestinal transplant model and its pharmacokinetic profile. |
1999 |
Transplant. Proc. |
pmid:10578276
|
Vincenti F et al. |
Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. |
2005 |
Transplant. Proc. |
pmid:15848604
|
DemirbaÅŸ A et al. |
Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients. |
2004 Jan-Feb |
Transplant. Proc. |
pmid:15013338
|
Fan Y et al. |
Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. |
2009 |
Transplant. Proc. |
pmid:19545736
|
Gozdowska J et al. |
Tolerance of enteric-coated mycophenolate sodium in combination with calcineurin inhibitor in kidney transplant recipients: Polish experience. |
2011 |
Transplant. Proc. |
pmid:21996197
|
Alessiani M et al. |
Total orthotopic small bowel transplantation in swine under FK 506. |
1994 |
Transplant. Proc. |
pmid:7518148
|
Date K et al. |
Effect of FK 506 on graft survival in rat small intestinal allografts. |
1992 |
Transplant. Proc. |
pmid:1376516
|
Murase N et al. |
Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. |
1995 |
Transplant. Proc. |
pmid:7533386
|
Ishibashi M et al. |
Effect of FK 506 on generation of activated macrophages invading rejected skin allografts in rats: discrepancy of in vitro versus in vivo effects. |
1991 |
Transplant. Proc. |
pmid:1721330
|
Hasegawa A et al. |
Improvement of quality of life in tacrolimus-based pediatric renal transplant recipients and their caregivers, including donors. |
2005 |
Transplant. Proc. |
pmid:15919461
|
Junge G et al. |
Microchimerism in patients after orthotopic liver transplantation: a prognostic indicator? |
2002 |
Transplant. Proc. |
pmid:12176475
|
Viganò J et al. |
The role of basiliximab induction therapy in adult-to-adult living-related transplantation and deceased donor liver transplantation: a comparative retrospective analysis of a single-center series. |
2008 Jul-Aug |
Transplant. Proc. |
pmid:18675099
|
Ciftci HS et al. |
Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism. |
2017 |
Transplant. Proc. |
pmid:28340819
|
Kilian K et al. |
FK-506 (tacrolimus) therapy for an unusual SLE-like disease. |
1998 |
Transplant. Proc. |
pmid:9865322
|
Rodrigues N et al. |
Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study. |
2017 |
Transplant. Proc. |
pmid:28457398
|
Perego C et al. |
Orthotopic liver-small bowel transplantation in pigs: study of immunologic parameters during therapy with FK 506-based immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907908
|
Park CS et al. |
Tetrahydrocurcumin Ameliorates Tacrolimus-Induced Nephrotoxicity Via Inhibiting Apoptosis. |
2018 |
Transplant. Proc. |
pmid:30401411
|
Jabiry-Zieniewicz Z et al. |
Outcome of four high-risk pregnancies in female liver transplant recipients on tacrolimus immunosuppression. |
2006 Jan-Feb |
Transplant. Proc. |
pmid:16504718
|
Moreno JM et al. |
Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12962831
|
Shapiro R et al. |
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176521
|
Nishimura Y et al. |
A trial to obtain donor-specific immunotolerance using a vascularized thymus allograft. |
1998 |
Transplant. Proc. |
pmid:9838684
|
Damotte D et al. |
Morphologic features of large bowel biopsies in combined small and large bowel transplantations could predict clinical rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083252
|
Townamchai N et al. |
A Simple Novel Technique to Estimate Tacrolimus Dosages During the Early Post Kidney Transplantation Period. |
2015 |
Transplant. Proc. |
pmid:26518946
|
Ota H et al. |
Intrathymic microchimerism predicts rejection response in allograft recipients. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123279
|
Kiuchi T et al. |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects. |
1996 |
Transplant. Proc. |
pmid:8962229
|
Inagaki K et al. |
Effects of FK506 and 15-deoxyspergualin in rat orthotopic liver transplantation. |
1989 |
Transplant. Proc. |
pmid:2468210
|
Scantlebury V et al. |
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1721395
|
Jordán de Luna C et al. |
Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels. |
2011 Jul-Aug |
Transplant. Proc. |
pmid:21839244
|
Bunnapradist S and Takemoto SK |
Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors. |
2003 |
Transplant. Proc. |
pmid:14611971
|
Salizzoni M et al. |
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377521
|
El Haggan W et al. |
One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine. |
2002 |
Transplant. Proc. |
pmid:12176589
|
Adibelli Z et al. |
An unusual presentation of sirolimus associated cough in a renal transplant recipient. |
2007 |
Transplant. Proc. |
pmid:18089408
|
Ishibashi M et al. |
Experimental study of tacrolimus immunosuppression on the mode of administration: efficacy of constant intravenous infusion avoiding C(max). |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266958
|
Van Buren D et al. |
Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9723299
|
Langrehr JM et al. |
Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness. |
1991 |
Transplant. Proc. |
pmid:1721425
|
Zou XM et al. |
Immunosuppressive effect of FK506 on orthotopic liver and small bowel xenotransplantation (xenoOLTx and SBTx). |
1996 |
Transplant. Proc. |
pmid:8658729
|
Honbo T et al. |
The oral dosage form of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445068
|
Fuchs U et al. |
Clinical outcome in cardiac transplant recipients receiving tacrolimus retard. |
2013 |
Transplant. Proc. |
pmid:23769094
|
Cintra-Cabrera M et al. |
Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review. |
2018 |
Transplant. Proc. |
pmid:29579856
|
Meiser BM et al. |
Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model. |
1992 |
Transplant. Proc. |
pmid:1384201
|
Shi G et al. |
Variation of CD4CD25Foxp3 Regulatory T Cells and Th17 Cells in the Peripheral Blood of Human Liver Allograft Patients With Long-term Survival. |
2017 |
Transplant. Proc. |
pmid:28923634
|
Hesse CJ et al. |
Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12431679
|
Duzova A et al. |
Triple immunosuppression with tacrolimus in pediatric renal transplantation: single-center experience. |
2008 Jan-Feb |
Transplant. Proc. |
pmid:18261567
|
Preston R et al. |
FK 506 as primary immunosuppressive therapy in renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636493
|
Takaya S et al. |
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1703691
|
Han SY et al. |
Effect of tacrolimus on the production of oxygen free radicals in hepatic mitochondria. |
2006 |
Transplant. Proc. |
pmid:16980054
|
White SA et al. |
Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10700949
|